Enterprise Value to EBITDA Multiple ratio Analysis of Abcellera Biologics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-11.01
Period Ending - Dec-22
Excellent EV to EBITDA
3.09
Growth
-456.49 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-6.74
EV to EBITDA Analysis of Abcellera Biologics Inc
| EV to EBITDA Ratio of ABCL drastically fell by -456.49 % this year. |
| EV to EBITDA Ratio with value of 3.09 was highest in Year Dec-22 in last Five Years. |
| EV to EBITDA Ratio with value of -4349.12 was lowest in Year Dec-19 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -11.01 is Greater than Average EV to EBITDA of -1632.20 in last five years. |
Other EV to EBITDA Related Info of ABCL that may interest you.
Abcellera Biologics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ABCL | 3.92 | 4.04 | 2.97 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Abcellera Biologics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| EV to EBITDA | -11.01 | 3.09 | -3806.54 | 2.60 | -4349.12 | 642.30 |
| Change | -456.49 % | 100.08 % | -146699.41 % | 100.06 % | -777.12 % |
FY Chart of Enterprise Value to EBITDA Multiple of Abcellera Biologics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)